logo
logo

Acurx Pharmaceuticals, Llc announced it raised $2.87 Million in an amended filing from an offering of $7 Million

May 31, 2018about 7 years ago

Amount Raised

$2.87 Million

Staten IslandBiopharmaTherapeuticsPharmaceuticalBiotechnology

Company Information

Company

Acurx Pharmaceuticals

Location

Staten Island, New York, United States

About

Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Their approach includes developing antibiotic candidates with a Gram-positive selective spectrum that blocks the active site of specific bacterial enzymes, inhibiting DNA replication. The company's R&D pipeline targets various Gram-positive bacteria such as MRSA and drug-resistant Streptococcus pneumoniae. Acurx is committed to addressing significant unmet medical needs in the antibiotic space.

FundzWatch™ Score

63
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People